In Newsweek, Sharon Begley says that NIH has to make translational medicine even more of a priority, citing stumbling blocks to the effort such as "academic advancement." She writes that academia prizes securing grants and publishing in highly-rated journals, but that those top journals are not interested in treatments -- only more niche-ones are -- and thus progress slows down.